Additional file 1 of Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy

Figshare 2026 Open access

Read full text

Authors: Katsuyuki Hazama, Toru Imai, Naohiro Tochikura, Shinsaku Washinosu, Susumu Ootsuka, Hanada, Kazuhiko

DOI: 10.6084/m9.figshare.31054540

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Pharmacovigilance and Adverse Drug Reactions